Gene Therapy and Regulation (GTR)

The aim of Gene Therapy and Regulation is to meet the demand for an international interdisciplinary journal integrating the publication of all aspects of research on gene therapy, stem cell therapy and ancillary basic cell/molecular biology approaches, including stem cell research, molecular cloning/sequencing, and gene regulation. The journal fulfils this aim by publishing regular research/clinical articles, short communications, and method and review papers. Gene Therapy and Regulation welcomes submissions of papers which report original research data on gene therapy, stem/progenitor cell therapy and tissue engineering, gene regulation, stem cell characterization/manipulation, epigenetic reprogramming, RNA/DNA transfer into mammalian cells and subsequent long term/transient gene expression, alteration or inactivation. Papers from both basic research (molecular cloning/sequencing, gene regulation/networks, design and development of vectors, delivery systems, biological and therapeutic effects, stem cell biology/engineering, cellular and animal models) and from gene/cell therapy clinical trials or investigations will be considered.

Gene Therapy and Regulation (GTR) is :-

• International, Peer-Reviewed, Open Access, Refereed, Gene Therapy, Stem Cell Therapy, Molecular Biology, Cell Biology, Tissue Engineering , Online or Print , Yearly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1388-9532, E-ISSN: 1568-5586, Established: 2006,
• Provides Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE